Bobak Azamian is the founder of Tarsus Pharmaceuticals. Tarsus Pharmaceuticals has raised $60M in total funding. Latest round: Series B.
Bobak Azamian is the Co-Founder & CEO of Tarsus Pharmaceuticals, a company focused on addressing unmet needs in eye care and other conditions. In January 2020, Tarsus Pharmaceuticals raised a $60 million Series B financing round to advance their lead product, TP-03, for Demodex blepharitis, into Phase 2b/3 trials. The company's therapies include XDEMVY®, an FDA-approved treatment for Demodex blepharitis.
Full founder directory · Investor directory · Company funding database · Fundraising library